nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—Alkylating Activity—Temozolomide—skin cancer	0.485	0.556	CiPCiCtD
Procarbazine—Alkylating Activity—Dacarbazine—skin cancer	0.388	0.444	CiPCiCtD
Procarbazine—CYP1B1—Docetaxel—skin cancer	0.054	1	CbGbCtD
Procarbazine—Anxiety—Imiquimod—skin cancer	0.000178	0.00245	CcSEcCtD
Procarbazine—Sweating increased—Temozolomide—skin cancer	0.000176	0.00242	CcSEcCtD
Procarbazine—Dry mouth—Imiquimod—skin cancer	0.000175	0.00241	CcSEcCtD
Procarbazine—Decreased appetite—Vemurafenib—skin cancer	0.000175	0.0024	CcSEcCtD
Procarbazine—Stomatitis—Dactinomycin—skin cancer	0.000174	0.00239	CcSEcCtD
Procarbazine—Fatigue—Vemurafenib—skin cancer	0.000173	0.00238	CcSEcCtD
Procarbazine—Haemoglobin—Bleomycin—skin cancer	0.000172	0.00237	CcSEcCtD
Procarbazine—Constipation—Vemurafenib—skin cancer	0.000172	0.00236	CcSEcCtD
Procarbazine—Pancytopenia—Temozolomide—skin cancer	0.000172	0.00236	CcSEcCtD
Procarbazine—Oedema—Imiquimod—skin cancer	0.000172	0.00236	CcSEcCtD
Procarbazine—Haemorrhage—Bleomycin—skin cancer	0.000172	0.00236	CcSEcCtD
Procarbazine—Infection—Imiquimod—skin cancer	0.00017	0.00234	CcSEcCtD
Procarbazine—Shock—Imiquimod—skin cancer	0.000169	0.00232	CcSEcCtD
Procarbazine—Tachycardia—Imiquimod—skin cancer	0.000167	0.0023	CcSEcCtD
Procarbazine—Pollakiuria—Temozolomide—skin cancer	0.000167	0.0023	CcSEcCtD
Procarbazine—Dysphagia—Fluorouracil—skin cancer	0.000167	0.00229	CcSEcCtD
Procarbazine—Hyperhidrosis—Imiquimod—skin cancer	0.000166	0.00228	CcSEcCtD
Procarbazine—Photosensitivity reaction—Temozolomide—skin cancer	0.000165	0.00227	CcSEcCtD
Procarbazine—Eosinophilia—Fluorouracil—skin cancer	0.000165	0.00227	CcSEcCtD
Procarbazine—Anorexia—Imiquimod—skin cancer	0.000163	0.00225	CcSEcCtD
Procarbazine—Angina pectoris—Fluorouracil—skin cancer	0.000162	0.00223	CcSEcCtD
Procarbazine—Pneumonia—Temozolomide—skin cancer	0.000162	0.00223	CcSEcCtD
Procarbazine—Flushing—Bleomycin—skin cancer	0.000159	0.00219	CcSEcCtD
Procarbazine—Body temperature increased—Vemurafenib—skin cancer	0.000159	0.00219	CcSEcCtD
Procarbazine—Pancytopenia—Fluorouracil—skin cancer	0.000158	0.00217	CcSEcCtD
Procarbazine—Neuropathy peripheral—Temozolomide—skin cancer	0.000158	0.00217	CcSEcCtD
Procarbazine—Stomatitis—Temozolomide—skin cancer	0.000157	0.00216	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000156	0.00215	CcSEcCtD
Procarbazine—Deafness—Docetaxel—skin cancer	0.000155	0.00214	CcSEcCtD
Procarbazine—Insomnia—Imiquimod—skin cancer	0.000155	0.00213	CcSEcCtD
Procarbazine—Paraesthesia—Imiquimod—skin cancer	0.000154	0.00212	CcSEcCtD
Procarbazine—Chills—Bleomycin—skin cancer	0.000154	0.00212	CcSEcCtD
Procarbazine—Somnolence—Imiquimod—skin cancer	0.000152	0.0021	CcSEcCtD
Procarbazine—Photosensitivity reaction—Fluorouracil—skin cancer	0.000152	0.00209	CcSEcCtD
Procarbazine—Alopecia—Bleomycin—skin cancer	0.000152	0.00208	CcSEcCtD
Procarbazine—Pneumonia—Fluorouracil—skin cancer	0.000149	0.00205	CcSEcCtD
Procarbazine—Decreased appetite—Imiquimod—skin cancer	0.000149	0.00205	CcSEcCtD
Procarbazine—Flushing—Dactinomycin—skin cancer	0.000148	0.00204	CcSEcCtD
Procarbazine—Hypersensitivity—Vemurafenib—skin cancer	0.000148	0.00204	CcSEcCtD
Procarbazine—Fatigue—Imiquimod—skin cancer	0.000148	0.00203	CcSEcCtD
Procarbazine—Pain—Imiquimod—skin cancer	0.000147	0.00202	CcSEcCtD
Procarbazine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000146	0.002	CcSEcCtD
Procarbazine—Haemoglobin—Temozolomide—skin cancer	0.000145	0.002	CcSEcCtD
Procarbazine—Stomatitis—Fluorouracil—skin cancer	0.000145	0.00199	CcSEcCtD
Procarbazine—Haemorrhage—Temozolomide—skin cancer	0.000145	0.00199	CcSEcCtD
Procarbazine—Asthenia—Vemurafenib—skin cancer	0.000144	0.00198	CcSEcCtD
Procarbazine—Hallucination—Temozolomide—skin cancer	0.000144	0.00198	CcSEcCtD
Procarbazine—Chills—Dactinomycin—skin cancer	0.000144	0.00197	CcSEcCtD
Procarbazine—Pruritus—Vemurafenib—skin cancer	0.000142	0.00196	CcSEcCtD
Procarbazine—Lethargy—Docetaxel—skin cancer	0.000142	0.00195	CcSEcCtD
Procarbazine—Alopecia—Dactinomycin—skin cancer	0.000141	0.00194	CcSEcCtD
Procarbazine—Feeling abnormal—Imiquimod—skin cancer	0.000141	0.00194	CcSEcCtD
Procarbazine—Gastrointestinal pain—Imiquimod—skin cancer	0.00014	0.00193	CcSEcCtD
Procarbazine—Epistaxis—Fluorouracil—skin cancer	0.00014	0.00193	CcSEcCtD
Procarbazine—Anaemia—Bleomycin—skin cancer	0.000138	0.0019	CcSEcCtD
Procarbazine—Diarrhoea—Vemurafenib—skin cancer	0.000138	0.00189	CcSEcCtD
Procarbazine—Urticaria—Imiquimod—skin cancer	0.000136	0.00187	CcSEcCtD
Procarbazine—Body temperature increased—Imiquimod—skin cancer	0.000136	0.00186	CcSEcCtD
Procarbazine—Abdominal pain—Imiquimod—skin cancer	0.000136	0.00186	CcSEcCtD
Procarbazine—Flushing—Temozolomide—skin cancer	0.000134	0.00185	CcSEcCtD
Procarbazine—Haemoglobin—Fluorouracil—skin cancer	0.000134	0.00184	CcSEcCtD
Procarbazine—Leukopenia—Bleomycin—skin cancer	0.000134	0.00184	CcSEcCtD
Procarbazine—Haemorrhage—Fluorouracil—skin cancer	0.000133	0.00183	CcSEcCtD
Procarbazine—Dizziness—Vemurafenib—skin cancer	0.000133	0.00183	CcSEcCtD
Procarbazine—Ataxia—Docetaxel—skin cancer	0.000131	0.0018	CcSEcCtD
Procarbazine—Cough—Bleomycin—skin cancer	0.00013	0.00179	CcSEcCtD
Procarbazine—Chills—Temozolomide—skin cancer	0.00013	0.00178	CcSEcCtD
Procarbazine—Anaemia—Dactinomycin—skin cancer	0.000129	0.00177	CcSEcCtD
Procarbazine—Vomiting—Vemurafenib—skin cancer	0.000128	0.00176	CcSEcCtD
Procarbazine—Alopecia—Temozolomide—skin cancer	0.000128	0.00176	CcSEcCtD
Procarbazine—Myalgia—Bleomycin—skin cancer	0.000127	0.00175	CcSEcCtD
Procarbazine—Rash—Vemurafenib—skin cancer	0.000127	0.00174	CcSEcCtD
Procarbazine—Dermatitis—Vemurafenib—skin cancer	0.000127	0.00174	CcSEcCtD
Procarbazine—Hypersensitivity—Imiquimod—skin cancer	0.000126	0.00174	CcSEcCtD
Procarbazine—Headache—Vemurafenib—skin cancer	0.000126	0.00173	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000125	0.00172	CcSEcCtD
Procarbazine—Leukopenia—Dactinomycin—skin cancer	0.000125	0.00171	CcSEcCtD
Procarbazine—Asthenia—Imiquimod—skin cancer	0.000123	0.00169	CcSEcCtD
Procarbazine—Confusional state—Bleomycin—skin cancer	0.000123	0.00169	CcSEcCtD
Procarbazine—Oedema—Bleomycin—skin cancer	0.000122	0.00168	CcSEcCtD
Procarbazine—Pruritus—Imiquimod—skin cancer	0.000121	0.00167	CcSEcCtD
Procarbazine—Infection—Bleomycin—skin cancer	0.000121	0.00166	CcSEcCtD
Procarbazine—Dysphagia—Docetaxel—skin cancer	0.00012	0.00165	CcSEcCtD
Procarbazine—Nausea—Vemurafenib—skin cancer	0.000119	0.00164	CcSEcCtD
Procarbazine—Thrombocytopenia—Bleomycin—skin cancer	0.000119	0.00164	CcSEcCtD
Procarbazine—Arrhythmia—Fluorouracil—skin cancer	0.000119	0.00164	CcSEcCtD
Procarbazine—Myalgia—Dactinomycin—skin cancer	0.000119	0.00163	CcSEcCtD
Procarbazine—Tremor—Temozolomide—skin cancer	0.000118	0.00162	CcSEcCtD
Procarbazine—Alopecia—Fluorouracil—skin cancer	0.000118	0.00162	CcSEcCtD
Procarbazine—Diarrhoea—Imiquimod—skin cancer	0.000117	0.00161	CcSEcCtD
Procarbazine—Angina pectoris—Docetaxel—skin cancer	0.000117	0.00161	CcSEcCtD
Procarbazine—Anaemia—Temozolomide—skin cancer	0.000116	0.0016	CcSEcCtD
Procarbazine—Anorexia—Bleomycin—skin cancer	0.000116	0.0016	CcSEcCtD
Procarbazine—Pancytopenia—Docetaxel—skin cancer	0.000114	0.00157	CcSEcCtD
Procarbazine—Hypotension—Bleomycin—skin cancer	0.000114	0.00157	CcSEcCtD
Procarbazine—Oedema—Dactinomycin—skin cancer	0.000114	0.00156	CcSEcCtD
Procarbazine—Dizziness—Imiquimod—skin cancer	0.000113	0.00156	CcSEcCtD
Procarbazine—Infection—Dactinomycin—skin cancer	0.000113	0.00155	CcSEcCtD
Procarbazine—Leukopenia—Temozolomide—skin cancer	0.000113	0.00155	CcSEcCtD
Procarbazine—Thrombocytopenia—Dactinomycin—skin cancer	0.000111	0.00153	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000111	0.00153	CcSEcCtD
Procarbazine—Cough—Temozolomide—skin cancer	0.00011	0.00151	CcSEcCtD
Procarbazine—Paraesthesia—Bleomycin—skin cancer	0.000109	0.0015	CcSEcCtD
Procarbazine—Convulsion—Temozolomide—skin cancer	0.000109	0.0015	CcSEcCtD
Procarbazine—Vomiting—Imiquimod—skin cancer	0.000109	0.0015	CcSEcCtD
Procarbazine—Hypertension—Temozolomide—skin cancer	0.000109	0.0015	CcSEcCtD
Procarbazine—Anorexia—Dactinomycin—skin cancer	0.000108	0.00149	CcSEcCtD
Procarbazine—Rash—Imiquimod—skin cancer	0.000108	0.00149	CcSEcCtD
Procarbazine—Dermatitis—Imiquimod—skin cancer	0.000108	0.00149	CcSEcCtD
Procarbazine—Pneumonia—Docetaxel—skin cancer	0.000108	0.00148	CcSEcCtD
Procarbazine—Headache—Imiquimod—skin cancer	0.000107	0.00148	CcSEcCtD
Procarbazine—Anaemia—Fluorouracil—skin cancer	0.000107	0.00147	CcSEcCtD
Procarbazine—Myalgia—Temozolomide—skin cancer	0.000107	0.00147	CcSEcCtD
Procarbazine—Arthralgia—Temozolomide—skin cancer	0.000107	0.00147	CcSEcCtD
Procarbazine—Anxiety—Temozolomide—skin cancer	0.000107	0.00147	CcSEcCtD
Procarbazine—Decreased appetite—Bleomycin—skin cancer	0.000106	0.00146	CcSEcCtD
Procarbazine—Neuropathy peripheral—Docetaxel—skin cancer	0.000105	0.00144	CcSEcCtD
Procarbazine—Dry mouth—Temozolomide—skin cancer	0.000105	0.00144	CcSEcCtD
Procarbazine—Stomatitis—Docetaxel—skin cancer	0.000104	0.00144	CcSEcCtD
Procarbazine—Jaundice—Docetaxel—skin cancer	0.000104	0.00144	CcSEcCtD
Procarbazine—Pain—Bleomycin—skin cancer	0.000104	0.00143	CcSEcCtD
Procarbazine—Leukopenia—Fluorouracil—skin cancer	0.000104	0.00143	CcSEcCtD
Procarbazine—Confusional state—Temozolomide—skin cancer	0.000104	0.00143	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000104	0.00142	CcSEcCtD
Procarbazine—Oedema—Temozolomide—skin cancer	0.000103	0.00141	CcSEcCtD
Procarbazine—Infection—Temozolomide—skin cancer	0.000102	0.0014	CcSEcCtD
Procarbazine—Nausea—Imiquimod—skin cancer	0.000102	0.0014	CcSEcCtD
Procarbazine—Epistaxis—Docetaxel—skin cancer	0.000101	0.00139	CcSEcCtD
Procarbazine—Thrombocytopenia—Temozolomide—skin cancer	0.000101	0.00138	CcSEcCtD
Procarbazine—Convulsion—Fluorouracil—skin cancer	0.000101	0.00138	CcSEcCtD
Procarbazine—Feeling abnormal—Bleomycin—skin cancer	0.0001	0.00138	CcSEcCtD
Procarbazine—Hyperhidrosis—Temozolomide—skin cancer	9.94e-05	0.00137	CcSEcCtD
Procarbazine—Myalgia—Fluorouracil—skin cancer	9.88e-05	0.00136	CcSEcCtD
Procarbazine—Decreased appetite—Dactinomycin—skin cancer	9.88e-05	0.00136	CcSEcCtD
Procarbazine—Fatigue—Dactinomycin—skin cancer	9.8e-05	0.00135	CcSEcCtD
Procarbazine—Anorexia—Temozolomide—skin cancer	9.8e-05	0.00135	CcSEcCtD
Procarbazine—Pain—Dactinomycin—skin cancer	9.72e-05	0.00134	CcSEcCtD
Procarbazine—Urticaria—Bleomycin—skin cancer	9.68e-05	0.00133	CcSEcCtD
Procarbazine—Haemoglobin—Docetaxel—skin cancer	9.67e-05	0.00133	CcSEcCtD
Procarbazine—Body temperature increased—Bleomycin—skin cancer	9.63e-05	0.00132	CcSEcCtD
Procarbazine—Haemorrhage—Docetaxel—skin cancer	9.62e-05	0.00132	CcSEcCtD
Procarbazine—Confusional state—Fluorouracil—skin cancer	9.55e-05	0.00131	CcSEcCtD
Procarbazine—Oedema—Fluorouracil—skin cancer	9.47e-05	0.0013	CcSEcCtD
Procarbazine—Infection—Fluorouracil—skin cancer	9.41e-05	0.00129	CcSEcCtD
Procarbazine—Feeling abnormal—Dactinomycin—skin cancer	9.36e-05	0.00129	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Temozolomide—skin cancer	9.36e-05	0.00129	CcSEcCtD
Procarbazine—Insomnia—Temozolomide—skin cancer	9.3e-05	0.00128	CcSEcCtD
Procarbazine—Gastrointestinal pain—Dactinomycin—skin cancer	9.29e-05	0.00128	CcSEcCtD
Procarbazine—Thrombocytopenia—Fluorouracil—skin cancer	9.27e-05	0.00127	CcSEcCtD
Procarbazine—Tachycardia—Fluorouracil—skin cancer	9.24e-05	0.00127	CcSEcCtD
Procarbazine—Paraesthesia—Temozolomide—skin cancer	9.23e-05	0.00127	CcSEcCtD
Procarbazine—Somnolence—Temozolomide—skin cancer	9.14e-05	0.00126	CcSEcCtD
Procarbazine—Anorexia—Fluorouracil—skin cancer	9.03e-05	0.00124	CcSEcCtD
Procarbazine—Abdominal pain—Dactinomycin—skin cancer	8.98e-05	0.00124	CcSEcCtD
Procarbazine—Body temperature increased—Dactinomycin—skin cancer	8.98e-05	0.00124	CcSEcCtD
Procarbazine—Hypersensitivity—Bleomycin—skin cancer	8.98e-05	0.00123	CcSEcCtD
Procarbazine—Decreased appetite—Temozolomide—skin cancer	8.93e-05	0.00123	CcSEcCtD
Procarbazine—Flushing—Docetaxel—skin cancer	8.93e-05	0.00123	CcSEcCtD
Procarbazine—Fatigue—Temozolomide—skin cancer	8.86e-05	0.00122	CcSEcCtD
Procarbazine—Hypotension—Fluorouracil—skin cancer	8.85e-05	0.00122	CcSEcCtD
Procarbazine—Pain—Temozolomide—skin cancer	8.79e-05	0.00121	CcSEcCtD
Procarbazine—Constipation—Temozolomide—skin cancer	8.79e-05	0.00121	CcSEcCtD
Procarbazine—Asthenia—Bleomycin—skin cancer	8.74e-05	0.0012	CcSEcCtD
Procarbazine—Chills—Docetaxel—skin cancer	8.63e-05	0.00119	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Fluorouracil—skin cancer	8.63e-05	0.00119	CcSEcCtD
Procarbazine—Pruritus—Bleomycin—skin cancer	8.62e-05	0.00119	CcSEcCtD
Procarbazine—Arrhythmia—Docetaxel—skin cancer	8.59e-05	0.00118	CcSEcCtD
Procarbazine—Insomnia—Fluorouracil—skin cancer	8.57e-05	0.00118	CcSEcCtD
Procarbazine—Paraesthesia—Fluorouracil—skin cancer	8.5e-05	0.00117	CcSEcCtD
Procarbazine—Alopecia—Docetaxel—skin cancer	8.5e-05	0.00117	CcSEcCtD
Procarbazine—Feeling abnormal—Temozolomide—skin cancer	8.47e-05	0.00116	CcSEcCtD
Procarbazine—Somnolence—Fluorouracil—skin cancer	8.42e-05	0.00116	CcSEcCtD
Procarbazine—Gastrointestinal pain—Temozolomide—skin cancer	8.4e-05	0.00116	CcSEcCtD
Procarbazine—Hypersensitivity—Dactinomycin—skin cancer	8.37e-05	0.00115	CcSEcCtD
Procarbazine—Decreased appetite—Fluorouracil—skin cancer	8.23e-05	0.00113	CcSEcCtD
Procarbazine—Urticaria—Temozolomide—skin cancer	8.17e-05	0.00112	CcSEcCtD
Procarbazine—Asthenia—Dactinomycin—skin cancer	8.15e-05	0.00112	CcSEcCtD
Procarbazine—Abdominal pain—Temozolomide—skin cancer	8.13e-05	0.00112	CcSEcCtD
Procarbazine—Body temperature increased—Temozolomide—skin cancer	8.13e-05	0.00112	CcSEcCtD
Procarbazine—Pain—Fluorouracil—skin cancer	8.1e-05	0.00111	CcSEcCtD
Procarbazine—Feeling abnormal—Fluorouracil—skin cancer	7.8e-05	0.00107	CcSEcCtD
Procarbazine—Diarrhoea—Dactinomycin—skin cancer	7.78e-05	0.00107	CcSEcCtD
Procarbazine—Vomiting—Bleomycin—skin cancer	7.75e-05	0.00107	CcSEcCtD
Procarbazine—Anaemia—Docetaxel—skin cancer	7.74e-05	0.00106	CcSEcCtD
Procarbazine—Rash—Bleomycin—skin cancer	7.68e-05	0.00106	CcSEcCtD
Procarbazine—Dermatitis—Bleomycin—skin cancer	7.68e-05	0.00106	CcSEcCtD
Procarbazine—Hypersensitivity—Temozolomide—skin cancer	7.57e-05	0.00104	CcSEcCtD
Procarbazine—Urticaria—Fluorouracil—skin cancer	7.52e-05	0.00103	CcSEcCtD
Procarbazine—Syncope—Docetaxel—skin cancer	7.51e-05	0.00103	CcSEcCtD
Procarbazine—Leukopenia—Docetaxel—skin cancer	7.5e-05	0.00103	CcSEcCtD
Procarbazine—Body temperature increased—Fluorouracil—skin cancer	7.49e-05	0.00103	CcSEcCtD
Procarbazine—Asthenia—Temozolomide—skin cancer	7.37e-05	0.00101	CcSEcCtD
Procarbazine—Loss of consciousness—Docetaxel—skin cancer	7.36e-05	0.00101	CcSEcCtD
Procarbazine—Cough—Docetaxel—skin cancer	7.31e-05	0.001	CcSEcCtD
Procarbazine—Pruritus—Temozolomide—skin cancer	7.27e-05	0.001	CcSEcCtD
Procarbazine—Convulsion—Docetaxel—skin cancer	7.26e-05	0.000998	CcSEcCtD
Procarbazine—Nausea—Bleomycin—skin cancer	7.24e-05	0.000995	CcSEcCtD
Procarbazine—Hypertension—Docetaxel—skin cancer	7.23e-05	0.000994	CcSEcCtD
Procarbazine—Vomiting—Dactinomycin—skin cancer	7.23e-05	0.000993	CcSEcCtD
Procarbazine—Rash—Dactinomycin—skin cancer	7.17e-05	0.000985	CcSEcCtD
Procarbazine—Myalgia—Docetaxel—skin cancer	7.13e-05	0.00098	CcSEcCtD
Procarbazine—Arthralgia—Docetaxel—skin cancer	7.13e-05	0.00098	CcSEcCtD
Procarbazine—Diarrhoea—Temozolomide—skin cancer	7.03e-05	0.000967	CcSEcCtD
Procarbazine—Hypersensitivity—Fluorouracil—skin cancer	6.98e-05	0.000959	CcSEcCtD
Procarbazine—Dry mouth—Docetaxel—skin cancer	6.97e-05	0.000959	CcSEcCtD
Procarbazine—Confusional state—Docetaxel—skin cancer	6.89e-05	0.000948	CcSEcCtD
Procarbazine—Oedema—Docetaxel—skin cancer	6.84e-05	0.00094	CcSEcCtD
Procarbazine—Dizziness—Temozolomide—skin cancer	6.8e-05	0.000935	CcSEcCtD
Procarbazine—Infection—Docetaxel—skin cancer	6.79e-05	0.000934	CcSEcCtD
Procarbazine—Nausea—Dactinomycin—skin cancer	6.75e-05	0.000928	CcSEcCtD
Procarbazine—Shock—Docetaxel—skin cancer	6.72e-05	0.000925	CcSEcCtD
Procarbazine—Pruritus—Fluorouracil—skin cancer	6.7e-05	0.000921	CcSEcCtD
Procarbazine—Thrombocytopenia—Docetaxel—skin cancer	6.69e-05	0.00092	CcSEcCtD
Procarbazine—Tachycardia—Docetaxel—skin cancer	6.67e-05	0.000917	CcSEcCtD
Procarbazine—Vomiting—Temozolomide—skin cancer	6.54e-05	0.000899	CcSEcCtD
Procarbazine—Anorexia—Docetaxel—skin cancer	6.52e-05	0.000896	CcSEcCtD
Procarbazine—Rash—Temozolomide—skin cancer	6.48e-05	0.000891	CcSEcCtD
Procarbazine—Diarrhoea—Fluorouracil—skin cancer	6.48e-05	0.000891	CcSEcCtD
Procarbazine—Dermatitis—Temozolomide—skin cancer	6.47e-05	0.00089	CcSEcCtD
Procarbazine—Headache—Temozolomide—skin cancer	6.44e-05	0.000885	CcSEcCtD
Procarbazine—Hypotension—Docetaxel—skin cancer	6.39e-05	0.000878	CcSEcCtD
Procarbazine—Dizziness—Fluorouracil—skin cancer	6.26e-05	0.000861	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Docetaxel—skin cancer	6.23e-05	0.000856	CcSEcCtD
Procarbazine—Insomnia—Docetaxel—skin cancer	6.18e-05	0.00085	CcSEcCtD
Procarbazine—Paraesthesia—Docetaxel—skin cancer	6.14e-05	0.000844	CcSEcCtD
Procarbazine—Nausea—Temozolomide—skin cancer	6.11e-05	0.000839	CcSEcCtD
Procarbazine—Somnolence—Docetaxel—skin cancer	6.08e-05	0.000836	CcSEcCtD
Procarbazine—Vomiting—Fluorouracil—skin cancer	6.02e-05	0.000828	CcSEcCtD
Procarbazine—Rash—Fluorouracil—skin cancer	5.97e-05	0.000821	CcSEcCtD
Procarbazine—Dermatitis—Fluorouracil—skin cancer	5.97e-05	0.00082	CcSEcCtD
Procarbazine—Decreased appetite—Docetaxel—skin cancer	5.94e-05	0.000817	CcSEcCtD
Procarbazine—Headache—Fluorouracil—skin cancer	5.93e-05	0.000816	CcSEcCtD
Procarbazine—Fatigue—Docetaxel—skin cancer	5.89e-05	0.00081	CcSEcCtD
Procarbazine—Constipation—Docetaxel—skin cancer	5.85e-05	0.000804	CcSEcCtD
Procarbazine—Pain—Docetaxel—skin cancer	5.85e-05	0.000804	CcSEcCtD
Procarbazine—Feeling abnormal—Docetaxel—skin cancer	5.63e-05	0.000774	CcSEcCtD
Procarbazine—Nausea—Fluorouracil—skin cancer	5.63e-05	0.000773	CcSEcCtD
Procarbazine—Gastrointestinal pain—Docetaxel—skin cancer	5.59e-05	0.000769	CcSEcCtD
Procarbazine—Abdominal pain—Docetaxel—skin cancer	5.4e-05	0.000743	CcSEcCtD
Procarbazine—Body temperature increased—Docetaxel—skin cancer	5.4e-05	0.000743	CcSEcCtD
Procarbazine—Hypersensitivity—Docetaxel—skin cancer	5.04e-05	0.000692	CcSEcCtD
Procarbazine—Asthenia—Docetaxel—skin cancer	4.9e-05	0.000674	CcSEcCtD
Procarbazine—Pruritus—Docetaxel—skin cancer	4.84e-05	0.000665	CcSEcCtD
Procarbazine—Diarrhoea—Docetaxel—skin cancer	4.68e-05	0.000643	CcSEcCtD
Procarbazine—Dizziness—Docetaxel—skin cancer	4.52e-05	0.000622	CcSEcCtD
Procarbazine—Vomiting—Docetaxel—skin cancer	4.35e-05	0.000598	CcSEcCtD
Procarbazine—Rash—Docetaxel—skin cancer	4.31e-05	0.000593	CcSEcCtD
Procarbazine—Dermatitis—Docetaxel—skin cancer	4.31e-05	0.000592	CcSEcCtD
Procarbazine—Headache—Docetaxel—skin cancer	4.28e-05	0.000589	CcSEcCtD
Procarbazine—Nausea—Docetaxel—skin cancer	4.06e-05	0.000558	CcSEcCtD
